| Metric | Q3 2016 | Q2 2016 | Q3 2015 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $5.7B | — | — | — | — |
| Op. Income | $455M | — | — | — | — |
| Gross Margin | 21.3% | — | — | — | — |
| Net Margin | 0.7% | — | — | — | — |
| EPS (Diluted) | $0.03 | — | — | — | — |
| Free Cash Flow | $102M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $5.7B |
| Cost of Revenue | $4.5B |
| GROSS PROFIT | $1.2B |
| R&D Expenses | $211M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $546M |
| Other Expenses | $0 |
| Operating Expenses | $757M |
| Cost & Expenses | $5.3B |
| OPERATING INCOME | $455M |
| Interest Income | $0 |
| Interest Expense | $273M |
| Other Income/Expenses | -$397M |
| INCOME BEFORE TAX | $58M |
| Income Tax Expense | $32M |
| Net Income from Continuing Ops | $39M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $39M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $39M |
| D&A | $314M |
| EBIT | $331M |
| EBITDA | $645M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $5.7B |
| Cost of Revenue | $4.5B |
| GROSS PROFIT | $1.2B |
| R&D Expenses | $211M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $546M |
| Other Expenses | $0 |
| Operating Expenses | $757M |
| Cost & Expenses | $5.3B |
| OPERATING INCOME | $455M |
| Interest Income | $0 |
| Interest Expense | $273M |
| Other Income/Expenses | -$397M |
| INCOME BEFORE TAX | $58M |
| Income Tax Expense | $32M |
| Net Income from Continuing Ops | $39M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $39M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $39M |
| D&A | $314M |
| EBIT | $331M |
| EBITDA | $645M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $39M |
| Depreciation & Amortization | $314M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $81M |
| Change in Working Capital | $208M |
| OPERATING CASH FLOW | $642M |
| Capital Expenditure | -$540M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $205M |
| NET CASH FROM INVESTING | -$335M |
| Net Debt Issuance | $196M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$1M |
| Other Financing Activities | -$259M |
| NET CASH FROM FINANCING | -$64M |
| FREE CASH FLOW | $102M |
| Net Change in Cash | $251M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $5.1B |
| Short-Term Investments | $0 |
| Net Receivables | $19.3B |
| Inventory | $6.7B |
| Other Current Assets | $740M |
| TOTAL CURRENT ASSETS | $31.9B |
| PP&E (Net) | $8.5B |
| Goodwill | $2.5B |
| Intangible Assets | $786M |
| Long-Term Investments | $494M |
| Tax Assets | $1.0B |
| Other Non-Current Assets | $2.0B |
| TOTAL NON-CURRENT ASSETS | $15.2B |
| TOTAL ASSETS | $47.1B |
| Account Payables | $5.2B |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $625M |
| TOTAL CURRENT LIABILITIES | $7.2B |
| Long-Term Debt | $26.3B |
| Deferred Revenue NC | $2.4B |
| Deferred Tax Liabilities | $75M |
| Other Non-Current Liabilities | $6.6B |
| TOTAL NON-CURRENT LIABILITIES | $35.4B |
| TOTAL LIABILITIES | $42.6B |
| Common Stock | $25M |
| Additional Paid-In Capital | $4.4B |
| Retained Earnings | $1.7B |
| Treasury Stock | -$9M |
| Accum. Other Comp. Income | -$1.7B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $4.5B |
| Minority Interest | $30M |
| TOTAL EQUITY | $4.5B |
| TOTAL LIABILITIES & EQUITY | $47.1B |
| Total Debt | $26.3B |
| Net Debt | $21.2B |
